Born are twins without a predisposition to suffer from hereditary colon cancer by applying a new genetic diagnostic technique

  • This is the first time in the world that the birth of babies without this hereditary predisposition has been achieved through preimplantation genetic diagnosis for double factor (DF-**DGP).
  • This technique, developed by the UAB, allows for the simultaneous identification of whether the embryos are free from genetic alterations and whether the chromosomal endowment is normal.
  • Colon cancer is the third type of cancer that causes the most deaths in the West and results in over 650,000 deaths each year worldwide.

Barcelona, November 7, 2012.-The Unit of Cellular Biology and Medical Genetics of the Faculty of Medicine of the Universitat Autònoma de Barcelona (UAB) –led by Dr. Joaquima Navarro– and the Assisted Reproduction Program Fundació Puigvert-Hospital de Sant Pau –directed by Dr. Joaquim Calaf and with Dr. Ana Polo and Dr. Olga Martínez Passarell as responsible for the DGP program– have achieved, for the first time in the world, the birth of twins without a mutation for hereditary non-polyposis colorectal cancer (HNPCC) or Lynch syndrome. This birth has been achieved through a cycle of preimplantation genetic diagnosis of double genetic factor (DF-*DGP). With this methodology, the mutation responsible for the hereditary disease and the complete chromosomal endowment of the developmental embryos are analyzed during the same in vitro fertilization (IVF) cycle.

Hereditary non-polyposis colorectal cancer (HNPCC) or Lynch syndrome is a rare monogenic pathology, mainly linked to mutations in DNA repair genes, which are important for maintaining genomic stability during the cell cycle. With 665,000 deaths per year worldwide, this is the third type of cancer that causes the most deaths in the West and the fourth most common form of cancer in the United States.

According to data extracted from the European Society of Human Reproduction and Embryology (ESHRE), less than 14% of embryos transferred to the maternal uterus in cycles of preimplantation genetic diagnosis (DGP) for monogenic diseases result in a pregnancy. One of the reasons for this low gestation rate may be the presence of alterations in the number of chromosomes of the transferred embryos that are not analyzed in standard DGP.

In this case, there were several family histories of digestive cancers. The couple, after undergoing genetic counseling, opted for DGP to avoid the transmission of Lynch syndrome to their offspring. The case was presented to the National Commission of Assisted Human Reproduction and, once authorized, the process to carry out the DGP was initiated. In order to increase the probability of gestation, the possibility of diagnosing not only the mutation in the embryos but also their chromosomal endowment through preimplantation genetic diagnosis of double genetic factor (DF-*DGP) was proposed. Thus, from the developmental embryos on day +3 obtained in IVF cycles, two cells (blastomeres) were analyzed: one was used for the study of the familial mutation and the other for the study of all chromosomes, using the comparative genomic hybridization (CGH) technique.

The DF-*DGP procedure applied in this case was as follows: twelve embryos could be analyzed for the familial mutation, with 5 of them being non-carriers of this mutation. Among these five, three were found to be chromosomally normal. Two of these three healthy embryos for both factors were transferred to the maternal uterus, resulting in a twin pregnancy. The final result was the birth of a boy and a girl, both free from Lynch syndrome. The postnatal genetic study confirmed the diagnosis that had been previously established.

About the Unit of Cellular Biology Medical Genetics of the Faculty of Medicine of the UAB

The Unit of Cellular Biology and Medical Genetics of the Universitat Autònoma de Barcelona (UAB) is located in the Faculty of Medicine of the Bellaterra university campus. This Unit is part of the Department of Cellular Biology, Physiology, and Immunology. The Unit is composed of teaching and research staff, integrated into a quality research group, recognized by the Generalitat de Catalunya, the Basic and Clinical Cytogenetics Research Group. Additionally, administrative and service staff, as well as contracted research support personnel, are also affiliated with the Unit. The main research lines being worked on are human reproduction, cancer, genotoxic effects, and chromosomal speciation.

The Unit of Cellular Biology and Medical Genetics of the UAB has received competitive funding continuously since 1994. It has received funding from La Marató de TV3 on two occasions (from 1994 to 1998 and from 1999 to 2001) and, subsequently, four FIS grants (Health Research Fund) from the Ministry of Health and Consumption.

The Unit is responsible for teaching various subjects in the undergraduate and/or degree studies of Medicine, Nursing, Physiotherapy, Speech Therapy, Biomedical Sciences, and Genetics. It also participates in the Master’s in Cellular Biology and the Doctorate in Cellular Biology.

The Unit also hosts undergraduate or degree students on internships and students in their final year of undergraduate or degree studies.

About the Assisted Reproduction Program Fundació Puigvert-Hospital de Sant Pau

The Assisted Reproduction Program (PRA) carried out jointly by Fundació Puigvert and the Hospital de la Santa Creu i Sant Pau is an initiative of both institutions that, at the time, had the vision to jointly address a health problem that affects, by concept, the couple. It leverages the experience of both institutions in their respective fields of Andrology and Reproductive Endocrinology.

In March 2011, the birth of the first baby in Spain without the familial mutation responsible for the predisposition to hereditary breast and ovarian cancer was announced. On that occasion, the Assisted Reproduction Program Fundació Puigvert-Hospital de Sant Pau successfully performed preimplantation genetic diagnosis on a carrier of the BRCA1 gene. This procedure resulted in the birth of a healthy baby who is not a carrier of the predisposition to breast cancer.

Fundació Puigvert has been the first center in the Catalan public health system to have a sperm bank (active since 1985), to perform artificial inseminations, and to cryopreserve sperm in oncological patients. In 1987, it already resulted in the first pregnancy through in vitro fertilization in the Catalan public network. Currently, it performs over 1,000 cycles of insemination and more than 500 of in vitro fertilization each year, in its different modalities.

The DGP began in 2001 within the public Assisted Reproduction program, with few cycles/year indicated for chromosomal alteration. Since its inception, the number and complexity of cases have gradually increased, requiring the collaboration of a multidisciplinary team of specialists in genetics, oncology, and neurology, among others. Currently, about 20 cycles of DGP are performed per year, prioritizing the indication of hereditary disease (more technically complex cycles that require more economic resources). Since then, this technique has been applied to more than a hundred couples, achieving pregnancies in 43% of the couples.